Quinn Opportunity Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,000	Closed	-$204K	–	338
2024 Q2	$204K	Buy	+5,000	New	+$204K	0.02%	218